FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Mather

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Tissue Distribution

Living Beings

Disorders

Neoplasms

Co-author Network

Publications

TOP 3
Sarah E Wythe; Taher E I Taher; Michele Bombardieri; Yuti Chernajovsky; Danielle DiCara; Ciara M Finucane; Rita Jones; Y K Stella Man; Stephen J Mather; Ahuva Nissim; Costantino Pitzalis
Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide.
Jonathan C Welti; David Robertson; Kevin Sharpe; Julie Soffe; Caroline J Springer; Antoinette van Weverwijk; Demelza Bird; Janine T Erler; Shane Foo; Julie Foster; Sophia Frentzas; Morgane Gourlaouen; Stephen J Mather; Roberto Pili; Thomas Powles; Natasha Preece; Andrew R Reynolds
Contrasting effects of sunitinib within in vivo models of metastasis.
Samir G Agrawal; Stephen J Mather
Pathogen identification by nuclear imaging--almost there?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Mather (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sarah E Wythe; Taher E I Taher; Michele Bombardieri; Yuti Chernajovsky; Danielle DiCara; Ciara M Finucane; Rita Jones; Y K Stella Man; Stephen J Mather; Ahuva Nissim; Costantino Pitzalis
Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide.
Annals of the rheumatic diseases 2013;72(1):129-35.
2012: Jonathan C Welti; David Robertson; Kevin Sharpe; Julie Soffe; Caroline J Springer; Antoinette van Weverwijk; Demelza Bird; Janine T Erler; Shane Foo; Julie Foster; Sophia Frentzas; Morgane Gourlaouen; Stephen J Mather; Roberto Pili; Thomas Powles; Natasha Preece; Andrew R Reynolds
Contrasting effects of sunitinib within in vivo models of metastasis.
Angiogenesis 2012;15(4):623-41.
2012: Samir G Agrawal; Stephen J Mather
Pathogen identification by nuclear imaging--almost there?
European journal of nuclear medicine and molecular imaging 2012;39(7):1173-4.
2011: Ciara M Finucane; Iain Murray; Jane K Sosabowski; Julie M Foster; Stephen J Mather
Quantitative Accuracy of Low-Count SPECT Imaging in Phantom and In Vivo Mouse Studies.
International journal of molecular imaging 2011;2011():197381.
2011: Syed Ali Raza Naqvi; Jane K Sosabowski; Saeed Ahamad Nagra; Malik M Ishfaq; Stephen J Mather; Torkjel Matzow
Radiopeptide internalisation and externalization assays: cell viability and radioligand integrity.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2011;69(1):68-74.
2010: Calogero D'Alessandria; Valentina di Gialleonardo; Marco Chianelli; Stephen J Mather; Erik F J de Vries; Francesco Scopinaro; Rudi A Dierck; Alberto Signore
Synthesis and optimization of the labeling procedure of 99mTc-HYNIC-interleukin-2 for in vivo imaging of activated T lymphocytes.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010;12(5):539-46.
2010: Antonio Saha; David Ellison; Gareth J Thomas; Sabarinath Vallath; Stephen J Mather; Ian R Hart; John FRancis Marshall
High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.
The Journal of pathology 2010;222(1):52-63.
2010: Syed Ali Raza Naqvi; Torkjel Matzow; Ciara Finucane; Saeed A Nagra; Malik M Ishfaq; Stephen J Mather; Jane Sosabowski
Insertion of a lysosomal enzyme cleavage site into the sequence of a radiolabeled neuropeptide influences cell trafficking in vitro and in vivo.
Cancer biotherapy & radiopharmaceuticals 2010;25(1):89-95.
2010: David Ellison; Jens Kaufman; Stephen J Mather
Automated radiolabelling of monoclonal antibodies with the Modular Lab system.
Nuclear medicine communications 2010;31(2):173-7.
2009: Jane K Sosabowski; Torkjel Matzow; Julie M Foster; Ciara Finucane; David Ellison; Susan A Watson; Stephen J Mather
Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(12):2082-9.
2009: Robert King; M Bashir-Uddin Surfraz; Ciara Finucane; Stefano C G Biagini; Philip J Blower; Stephen J Mather
99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(4):591-8.
2007: Jane K Sosabowski; Myrto Lee; Bronwen A Dekker; Ben P Simmons; Surjeet Singh; Hayden Beresford; Susan A Hagan; Andrew J McKenzie; Stephen J Mather; Susan A Watson
Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;31(2):102-11.
2007: Stephen J Mather; Andrew J McKenzie; Jane K Sosabowski; Teresa M Morris; David Ellison; Susan A Watson
Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):615-22.
2006: Alessio Annovazzi; Calogero D'Alessandria; Elena Bonanno; Stephen J Mather; Bart Cornelissen; Christophe Van De Wiele; Rudi A Dierckx; Maurizio Mattei; Graziana Palmieri; Francesco Scopinaro; Alberto Signore
Synthesis of 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes.
European journal of nuclear medicine and molecular imaging 2006;33(4):474-82.
2006: Jane K Sosabowski; Stephen J Mather
Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes.
Nature protocols 2006;1(2):972-6.
2004: Alberto Signore; Alessio Annovazzi; Raffaella Barone; Elena Bonanno; Calogero D'Alessandria; Marco Chianelli; Stephen J Mather; Ugo Bottoni; Chiara Panetta; Daniele Innocenzi; Francesco Scopinaro; Stefano Calvieri
99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1647-52.
2004: Frederica Corsetti; Marco Chianelli; Bart Cornelissen; Christophe Van De Wiele; Calogero D'Alessandria; Guido Slegers; Stephen J Mather; Umberto Di Mario; Sebastiano Filetti; Francesco Scopinaro; Alberto Signore
Radioiodinated recombinant human TSH: a novel radiopharmaceutical for thyroid cancer metastases detection.
Cancer biotherapy & radiopharmaceuticals 2004;19(1):57-63.
2004: Martin Kopecky; Vladimir Semecky; Frantisek Trejtnar; Milan Laznicek; Alice Laznickova; Petr Nachtigal; Clemens Decristoforo; Stephen J Mather; Helmut R Mäcke
Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.
Nuclear medicine and biology 2004;31(2):231-9.
2003: J Sosabowsky; L Melendez-Alafort; Stephen J Mather
Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2003;47(4):223-37.
2003: Michael Gabriel; Clemens Decristoforo; Eveline Donnemiller; Hanno Ulmer; Christine Watfah Rychlinski; Stephen J Mather; Roy Moncayo
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):708-16.
2003: Alessio Annovazzi; Livia Biancone; Renato Caviglia; Marco Chianelli; Gabriela Capriotti; Stephen J Mather; Renzo Caprilli; Francesco Pallone; Francesco Scopinaro; Alberto Signore
99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease.
European journal of nuclear medicine and molecular imaging 2003;30(3):374-82.
2002: Clemens Decristoforo; Stephen J Mather
The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2002;46(3):195-205.
2002: M Edreira; L Melendez-Alafort; Stephen J Mather
Optimization of the small-scale synthesis of DOTA-Tyr3 -octreotide.
Nuclear medicine communications 2002;23(5):493-9.
2002: A R Al-Yasi; MJ Carroll; David Ellison; Marie Granowska; Stephen J Mather; C A Wells; R Carpenter; Keith E Britton
Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1.
British journal of cancer 2002;86(6):870-8.
2001: MA Stalteri; Stephen J Mather
Hybridization and cell uptake studies with radiolabelled antisense oligonucleotides.
Nuclear medicine communications 2001;22(11):1171-9.
2000: Clemens Decristoforo; W Cholewinski; Eveline Donnemiller; Georg Riccabona; Roy Moncayo; Stephen J Mather
Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
European journal of nuclear medicine 2000;27(10):1580.
2000: Clemens Decristoforo; Stephen J Mather; W Cholewinski; Eveline Donnemiller; Georg Riccabona; Roy Moncayo
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.
European journal of nuclear medicine 2000;27(9):1318-25.
2000: Clemens Decristoforo; L Melendez-Alafort; Jane K Sosabowski; Stephen J Mather
99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(6):1114-9.
2000: David Ellison; MA Stalteri; Stephen J Mather
Photoreduction of monoclonal antibodies for conjugation and fragmentation.
BioTechniques 2000;28(2):318-22, 324-6.
2000: Frantisek Trejtnar; Milan Laznicek; Alice Laznickova; Stephen J Mather
Pharmacokinetics and renal handling of 99mTc-labeled peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(1):177-82.
1999: Clemens Decristoforo; Stephen J Mather
Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.
European journal of nuclear medicine 1999;26(8):869-76.
1999: Clemens Decristoforo; Stephen J Mather
99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution.
Nuclear medicine and biology 1999;26(4):389-96.
1999: Clemens Decristoforo; Stephen J Mather
Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide.
Bioconjugate chemistry 1999;10(3):431-8.
1999: MA Stalteri; S Bansal; R Hider; Stephen J Mather
Comparison of the stability of technetium-labeled peptides to challenge with cysteine.
Bioconjugate chemistry 1999;10(1):130-6.
1998: L Biassoni; Marie Granowska; MJ Carroll; Stephen J Mather; R Rodney Howell; David Ellison; F A MacNeill; C A Wells; R Carpenter; Keith E Britton
99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection.
British journal of cancer 1998;77(1):131-8.
1997: MA Stalteri; S J Parrott; V A Griffiths; J R Dilworth; Stephen J Mather
Uptake of 99Tcm-nitrido dithiocarbamate complexes by tumour cells.
Nuclear medicine communications 1997;18(9):870-7.
1997: Marco Chianelli; Alberto Signore; A R Fritzberg; Stephen J Mather
The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases.
Nuclear medicine and biology 1997;24(6):579-86.
1997: MA Stalteri; Stephen J Mather; B A Belinka; D J Coughlin; VU Chengazi; Keith E Britton
Site-specific conjugation and labelling of prostate antibody 7E11C5.3 (CYT-351) with technetium-99m.
European journal of nuclear medicine 1997;24(6):651-4.
1997: Marco Chianelli; Stephen J Mather; J Martin-Comin; Alberto Signore
Radiopharmaceuticals for the study of inflammatory processes: a review.
Nuclear medicine communications 1997;18(5):437-55.
1997: VU Chengazi; M R Feneley; David Ellison; MA Stalteri; A Granowski; Marie Granowska; Cyril C Nimmon; Stephen J Mather; R S Kirby; Keith E Britton
Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(5):675-82.
1996: Stephen J Mather; Marco Chianelli
Radiolabelled cytokines.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1996;40(3):290-300.
1996: M R Feneley; VU Chengazi; R S Kirby; C C Nimmon; Marie Granowska; Stephen J Mather; David Ellison; A R Granowski; Keith E Britton
Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351.
British journal of urology 1996;77(3):373-81.
1996: MA Stalteri; Stephen J Mather
Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
European journal of nuclear medicine 1996;23(2):178-87.
1996: Marie Granowska; L Biassoni; M J Carroll; R Rodney Howell; Stephen J Mather; David Ellison; A Granowski; Keith E Britton
Breast cancer 99mTc SM3 radioimmunoscintigraphy.
Acta oncologica (Stockholm, Sweden) 1996;35(3):319-21.
1995: MA Stalteri; Stephen J Mather
A cross-linked monoclonal antibody fragment for improved tumor targeting.
Bioconjugate chemistry 1995;6(2):179-86.
1994: Stephen J Mather; David Ellison
Radiolabelling of monoclonal antibodies.
Nuclear medicine communications 1994;15(9):772-4.
1993: Marie Granowska; Keith E Britton; Stephen J Mather; G Morris; David Ellison; S Soobramoney; I C Talbot; J M Northover
Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer.
European journal of nuclear medicine 1993;20(8):690-8.
1993: Marie Granowska; Keith E Britton; Stephen J Mather; D G Lowe; David Ellison; J Bomanji; J Burchell; J Taylor-Papadimitriou; C R Hudson; J H Shepherd
Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer.
European journal of nuclear medicine 1993;20(6):483-9.
1993: E Ur; J Bomanji; Stephen J Mather; Keith E Britton; J A H Wass; Ashley B Grossman; G Michael Besser
Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
Clinical endocrinology 1993;38(5):501-6.
1992: Stephen J Mather; E Ur; J Bomanji; David Ellison; G Michael Besser; Keith E Britton
Radiolabeled octreotide. What lessons for antibody-mediated targeting?
Cell biophysics 1992;21(1-3):93-107.
1992: K K Solanki; J Bomanji; J Moyes; Stephen J Mather; P J Trainer; Keith E Britton
A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG).
Nuclear medicine communications 1992;13(7):513-21.
1992: E Ur; Stephen J Mather; J Bomanji; David Ellison; Keith E Britton; Ashley B Grossman; J A H Wass; G Michael Besser
Pituitary imaging using a labelled somatostatin analogue in acromegaly.
Clinical endocrinology 1992;36(2):147-50.
1991: Stephen J Mather; David Ellison; J Nightingale; M Kamm; Keith E Britton
The design of a two-phase radiolabelled meal for gastric emptying studies.
Nuclear medicine communications 1991;12(5):409-16.
1991: Marie Granowska; Stephen J Mather; Keith E Britton
Diagnostic evaluation of 111In and 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer: correlations with surgery.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(4):413-24.
1990: T W Jobling; Marie Granowska; Keith E Britton; D G Lowe; Stephen J Mather; J Burchell; M Naeem; J H Shepherd
Radioimmunoscintigraphy of ovarian tumors using a new monoclonal antibody, SM-3.
Gynecologic oncology 1990;38(3):468-72.
1990: Stephen J Mather; David Ellison
Reduction-mediated technetium-99m labeling of monoclonal antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(5):692-7.
1990: Marie Granowska; Stephen J Mather; T Jobling; M Naeem; J Burchell; J Taylor-Papadimitriou; J Shepherd; Keith E Britton
Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours.
The International journal of biological markers 1990;5(2):89-96.
1989: Stephen J Mather; D M Tolley; G W White
Labelling monoclonal antibodies with yttrium-90.
European journal of nuclear medicine 1989;15(6):307-12.
1988: K K Solanki; Stephen J Mather; M A Janabi; Keith E Britton
A rapid method for the preparation of 99Tcm hexametazime-labelled leucocytes.
Nuclear medicine communications 1988;9(10):753-61.
1988: Marie Granowska; C C Nimmon; K E Britton; M Crowther; Stephen J Mather; M L Slevin; J H Shepherd
Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(5):599-607.